PLoS ONE (Dec 2010)

Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates.

  • Daniel Globisch,
  • Martin Münzel,
  • Markus Müller,
  • Stylianos Michalakis,
  • Mirko Wagner,
  • Susanne Koch,
  • Tobias Brückl,
  • Martin Biel,
  • Thomas Carell

DOI
https://doi.org/10.1371/journal.pone.0015367
Journal volume & issue
Vol. 5, no. 12
p. e15367

Abstract

Read online

5-Hydroxymethylcytosine (hmC) was recently detected as the sixth base in mammalian tissue at so far controversial levels. The function of the modified base is currently unknown, but it is certain that the base is generated from 5-methylcytosine (mC). This fuels the hypothesis that it represents an intermediate of an active demethylation process, which could involve further oxidation of the hydroxymethyl group to a formyl or carboxyl group followed by either deformylation or decarboxylation. Here, we use an ultra-sensitive and accurate isotope based LC-MS method to precisely determine the levels of hmC in various mouse tissues and we searched for 5-formylcytosine (fC), 5-carboxylcytosine (caC), and 5-hydroxymethyluracil (hmU) as putative active demethylation intermediates. Our data suggest that an active oxidative mC demethylation pathway is unlikely to occur. Additionally, we show using HPLC-MS analysis and immunohistochemistry that hmC is present in all tissues and cell types with highest concentrations in neuronal cells of the CNS.